2019 - Cambrex High Point Inc | Clinical Supplies Management Holdings Inc | Akorn Inc| Cerrilliant Corporation


Drug Enforcement Administration

Importer of Controlled Substances Registration

[Docket No. DEA-532]

ACTION: Notice of registration.

SUMMARY: The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as an importers of various basic classes of schedule I and II controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for these notices.

Company FR Docket Published
Cambrex High Point, Inc. 84 FR 44641 August 26, 2019
Clinical Supplies Management Holdings, Inc. 84 FR 44640 August 26, 2019
Akorn, Inc. 84 FR 44918 August 27, 2019
Cerrilliant Corporation 84 FR 45519 August 29, 2019

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable various basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and II controlled substances to the above listed companies.

Dated: 11/5/2019

William T. McDermott,
Assistant Administrator.